Clinical Trial Update: A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial (DUNE) evaluating the safety and clinical effect of Nexagon as a topical treatment for diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcers

Drugs mentioned

• NEXAGON

Snippet

Sponsor: OcuNexus Therapeutics, Inc. | Conditions: Diabetic Foot Ulcers | Phase 2 | Status: COMPLETED